We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
-15.16%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$1.4B
AUM Growth
-$1.05B
(-43%)
Cap. Flow
-$737M
Cap. Flow
% of AUM
-52.65%
Top 10 Holdings %
Top 10 Hldgs %
29.68%
Holding
181
New
76
Increased
18
Reduced
42
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$72.3M |
| 2 |
Applied Materials
AMAT
|
+$56.9M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$55.3M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$54.3M |
| 5 |
Analog Devices
ADI
|
+$33.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$69.5M |
| 2 |
Meta Platforms (Facebook)
META
|
+$63M |
| 3 |
NVIDIA
NVDA
|
+$61.4M |
| 4 |
ASML
ASML
|
+$60M |
| 5 |
Microchip Technology
MCHP
|
+$56.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 45.77% |
| 2 | Technology | 31.94% |
| 3 | Communication Services | 11.78% |
| 4 | Consumer Discretionary | 2.11% |
| 5 | Industrials | 1.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Cinemark Holdings
CNK
$4.43B
| $3.95M | 0.28% |
+387,843
| New | +$9.95M |
|
102
Jabil
JBL
$36B
| $3.78M | 0.27% |
+153,821
| New | +$5.36M |
|
103
HCA Healthcare
HCA
$88.9B
| $3.57M | 0.26% |
39,718
-281,689
| -88% | -$36.5M |
|
104
Nokia
NOK
$54.2B
| $3.3M | 0.24% |
1,065,772
-2,635,302
| -71% | -$9.8M |
|
|
CHNG
105
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $3.23M | 0.23% |
323,806
+65,420
| +25% | +$915K |
|
|
MTEM
106
DELISTED
Molecular Templates, Inc.
MTEM
| $3.21M | 0.23% |
+16,096
| New | +$3.52M |
|
|
PRVL
107
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
| $3.07M | 0.22% |
+251,532
| New | +$4M |
|
|
MYOK
108
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $3.02M | 0.22% |
64,308
-19,515
| -23% | -$1.25M |
|
|
P
109
Everpure Inc
P
$27.8B
| $2.84M | 0.2% |
231,038
-217,941
| -49% | -$3.53M |
|
|
TRIL
110
DELISTED
Trillium Therapeutics Inc.
TRIL
| $2.65M | 0.19% |
+654,781
| New | +$2.48M |
|
111
Abeona Therapeutics
ABEO
$384M
| $2.54M | 0.18% |
48,333
+16,443
| +52% | +$1.1M |
|
112
BioCryst Pharmaceuticals
BCRX
$2.29B
| $2.51M | 0.18% |
1,254,527
-1,163,302
| -48% | -$3.2M |
|
|
PVLA
113
Palvella Therapeutics
PVLA
$2.18B
| $2.38M | 0.17% |
+13,063
| New | +$3.29M |
|
114
Live Nation Entertainment
LYV
$42.8B
| $2.36M | 0.17% |
+51,924
| New | +$3.21M |
|
|
CHMA
115
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $2.08M | 0.15% |
+569,344
| New | +$2.53M |
|
116
Mercado Libre
MELI
$97.1B
| $2.06M | 0.15% |
+4,208
| New | +$2.59M |
|
|
AMRN
117
Amarin Corp
AMRN
$299M
| $1.8M | 0.13% |
+22,562
| New | +$7.5M |
|
118
Wolfspeed
WOLF
$1.32B
| $1.61M | 0.11% |
45,330
-116,878
| -72% | -$5.25M |
|
119
Coherent
COHR
$65.3B
| $1.52M | 0.11% |
53,426
-146,544
| -73% | -$4.76M |
|
120
Ligand Pharmaceuticals
LGND
$6.03B
| $1.49M | 0.11% |
+32,932
| New | +$1.87M |
|
|
INFN
121
DELISTED
Infinera Corporation Common Stock
INFN
| $1.42M | 0.1% |
267,964
-498,609
| -65% | -$3.42M |
|
122
Arcus Biosciences
RCUS
$3.57B
| $1.37M | 0.1% |
+98,516
| New | +$1.23M |
|
123
Waters Corp
WAT
$39.4B
| $1.36M | 0.1% |
+7,483
| New | +$1.58M |
|
124
Revolution Medicines
RVMD
$41.4B
| $1.2M | 0.09% |
+54,867
| New | +$1.52M |
|
125
NXP Semiconductors
NXPI
$58.3B
| $1.13M | 0.08% |
+13,673
| New | +$1.6M |
|
Similar funds
PAM
TCIIS
UIM
VAI
Woodline Partners's Q1 2020 Portfolio in Review
As of Q1 2020, Woodline Partners held 181 positions worth $1.4B, down 43% from $2.45B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Woodline Partners withdrew a net $737M in Q1 2020, closing 45 positions and reducing 42 holdings. Its most notable exit was Texas Instruments, an estimated $69.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 41% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Woodline Partners opened a new position in Pfizer worth $65.7M.
- Woodline Partners's largest Q1 2020 buy was Pfizer: 2,120,811 shares worth $65.7M.
- Woodline Partners added most to Immunomedics Inc in Q1 2020, an estimated $23M increase.
- Woodline Partners's biggest Q1 2020 reduction was NVIDIA, cutting an estimated $61.4M.
- Woodline Partners fully exited Texas Instruments in Q1 2020, selling an estimated $69.5M.
- Woodline Partners's ten largest holdings make up 30% of its $1.4B portfolio in Q1 2020.
- Woodline Partners opened 76 new positions and closed 45 in Q1 2020.
- Woodline Partners's portfolio value fell 43% quarter-over-quarter to $1.4B.
Based on Woodline Partners's 13F filing for Q1 2020, filed 15 May 2020.